Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke.

Zietemann V, Georgakis MK, Dondaine T, Müller C, Mendyk AM, Kopczak A, Hénon H, Bombois S, Wollenweber FA, Bordet R, Dichgans M.

Neurology. 2018 Nov 13;91(20):e1838-e1850. doi: 10.1212/WNL.0000000000006506. Epub 2018 Oct 17.

PMID:
30333158
2.

Validation of the Telephone Interview of Cognitive Status and Telephone Montreal Cognitive Assessment Against Detailed Cognitive Testing and Clinical Diagnosis of Mild Cognitive Impairment After Stroke.

Zietemann V, Kopczak A, Müller C, Wollenweber FA, Dichgans M.

Stroke. 2017 Nov;48(11):2952-2957. doi: 10.1161/STROKEAHA.117.017519. Epub 2017 Oct 17.

PMID:
29042492
3.

STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.

Sachdev PS, Lo JW, Crawford JD, Mellon L, Hickey A, Williams D, Bordet R, Mendyk AM, Gelé P, Deplanque D, Bae HJ, Lim JS, Brodtmann A, Werden E, Cumming T, Köhler S, Verhey FR, Dong YH, Tan HH, Chen C, Xin X, Kalaria RN, Allan LM, Akinyemi RO, Ogunniyi A, Klimkowicz-Mrowiec A, Dichgans M, Wollenweber FA, Zietemann V, Hoffmann M, Desmond DW, Linden T, Blomstrand C, Fagerberg B, Skoog I, Godefroy O, Barbay M, Roussel M, Lee BC, Yu KH, Wardlaw J, Makin SJ, Doubal FN, Chappell FM, Srikanth VK, Thrift AG, Donnan GA, Kandiah N, Chander RJ, Lin X, Cordonnier C, Moulin S, Rossi C, Sabayan B, Stott DJ, Jukema JW, Melkas S, Jokinen H, Erkinjuntti T, Mok VC, Wong A, Lam BY, Leys D, Hénon H, Bombois S, Lipnicki DM, Kochan NA; STROKOG.

Alzheimers Dement (Amst). 2016 Nov 18;7:11-23. doi: 10.1016/j.dadm.2016.10.006. eCollection 2017.

4.

Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment.

Wollenweber FA, Därr S, Müller C, Duering M, Buerger K, Zietemann V, Malik R, Brendel M, Ertl-Wagner B, Bartenstein P, Rominger A, Dichgans M.

Stroke. 2016 Oct;47(10):2645-8. doi: 10.1161/STROKEAHA.116.013778. Epub 2016 Aug 18.

PMID:
27539301
5.

Peripheral glucose levels and cognitive outcome after ischemic stroke-Results from the Munich Stroke Cohort.

Zietemann V, Wollenweber FA, Bayer-Karpinska A, Biessels GJ, Dichgans M.

Eur Stroke J. 2016 Mar;1(1):51-60. doi: 10.1177/2396987316631674. Epub 2016 Mar 1.

6.

Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts.

Duering M, Righart R, Wollenweber FA, Zietemann V, Gesierich B, Dichgans M.

Neurology. 2015 Apr 21;84(16):1685-92. doi: 10.1212/WNL.0000000000001502. Epub 2015 Mar 25.

7.

[Time-dependent confounding in the estimation of treatment effects in randomised trials with multimodal therapies--an illustration of the problem of time-dependent confounding by causal graphs].

Zietemann VD, Schuster T, Duell TH.

Gesundheitswesen. 2015 Jan;77(1):62-6. doi: 10.1055/s-0033-1355405. Epub 2013 Nov 7. Review. German.

PMID:
24203687
8.

The Determinants of Dementia After Stroke (DEDEMAS) Study: protocol and pilot data.

Wollenweber FA, Zietemann V, Rominger A, Opherk C, Bayer-Karpinska A, Gschwendtner A, Coloma Andrews L, Bürger K, Duering M, Dichgans M.

Int J Stroke. 2014 Apr;9(3):387-92. doi: 10.1111/ijs.12092. Epub 2013 Jul 9.

PMID:
23834337
9.

Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke.

Wollenweber FA, Zietemann V, Gschwendtner A, Opherk C, Dichgans M.

Stroke. 2013 May;44(5):1446-8. doi: 10.1161/STROKEAHA.113.000833. Epub 2013 Mar 12.

PMID:
23482604
10.

Prevention of vascular cognitive impairment.

Dichgans M, Zietemann V.

Stroke. 2012 Nov;43(11):3137-46. doi: 10.1161/STROKEAHA.112.651778. Epub 2012 Aug 30. Review. No abstract available.

PMID:
22935401
11.

Prediction of vascular risk after stroke - protocol and pilot data of the Prospective Cohort with Incident Stroke (PROSCIS).

Liman TG, Zietemann V, Wiedmann S, Jungehuelsing GJ, Endres M, Wollenweber FA, Wellwood I, Dichgans M, Heuschmann PU.

Int J Stroke. 2013 Aug;8(6):484-90. doi: 10.1111/j.1747-4949.2012.00871.x. Epub 2012 Aug 29.

PMID:
22928669
12.

Post-study therapy as a source of confounding in survival analysis of first-line studies in patients with advanced non-small-cell lung cancer.

Zietemann VD, Schuster T, Duell TH.

J Thorac Dis. 2011 Jun;3(2):88-98. doi: 10.3978/j.issn.2072-1439.2010.12.07.

13.

Erythrocyte membrane phospholipid polyunsaturated fatty acids are related to plasma C-reactive protein and adiponectin in middle-aged German women and men.

Enzenbach C, Kröger J, Zietemann V, Jansen EH, Fritsche A, Döring F, Boeing H, Schulze MB.

Eur J Nutr. 2011 Dec;50(8):625-36. doi: 10.1007/s00394-011-0169-4. Epub 2011 Feb 8.

PMID:
21301856
14.

Prevalence and effectiveness of first-, second-, and third-line systemic therapy in a cohort of unselected patients with advanced non-small cell lung cancer.

Zietemann V, Duell T.

Lung Cancer. 2011 Jul;73(1):70-7. doi: 10.1016/j.lungcan.2010.10.017. Epub 2010 Nov 20.

PMID:
21095039
15.

Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

Kröger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, Döring F, Joost HG, Boeing H, Schulze MB.

Am J Clin Nutr. 2011 Jan;93(1):127-42. doi: 10.3945/ajcn.110.005447. Epub 2010 Oct 27.

PMID:
20980488
16.

Genetic variation of the FADS1 FADS2 gene cluster and n-6 PUFA composition in erythrocyte membranes in the European Prospective Investigation into Cancer and Nutrition-Potsdam study.

Zietemann V, Kröger J, Enzenbach C, Jansen E, Fritsche A, Weikert C, Boeing H, Schulze MB.

Br J Nutr. 2010 Dec;104(12):1748-59. doi: 10.1017/S0007114510002916. Epub 2010 Aug 9.

PMID:
20691134
17.

Every-day clinical practice in patients with advanced non-small-cell lung cancer.

Zietemann V, Duell T.

Lung Cancer. 2010 May;68(2):273-7. doi: 10.1016/j.lungcan.2009.06.023. Epub 2009 Jul 25.

PMID:
19632737
18.

Progression-free survival as a surrogate endpoint in advanced breast cancer.

Miksad RA, Zietemann V, Gothe R, Schwarzer R, Conrads-Frank A, Schnell-Inderst P, Stollenwerk B, Siebert U.

Int J Technol Assess Health Care. 2008 Fall;24(4):371-83. doi: 10.1017/S0266462308080495.

19.

Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years.

Rosenberger A, Illig T, Korb K, Klopp N, Zietemann V, Wölke G, Meese E, Sybrecht G, Kronenberg F, Cebulla M, Degen M, Drings P, Gröschel A, Konietzko N, Kreymborg KG, Häussinger K, Höffken G, Jilge B, Ko YD, Morr H, Schmidt C, Schmidt EW, Täuscher D, Bickeböller H, Wichmann HE.

BMC Cancer. 2008 Feb 25;8:60. doi: 10.1186/1471-2407-8-60.

20.

Pharmacogenomics Bias - Systematic distortion of study results by genetic heterogeneity.

Siebert U, Sroczynski G, Zietemann V.

GMS Health Technol Assess. 2008 Apr 15;4:Doc03.

21.

[Social contact and depression in geriatric patients: is there an influence of gender?].

Zietemann V, Machens P, Mielck A, Kwetkat A.

Gesundheitswesen. 2007 Jun;69(6):345-52. German.

PMID:
17642039
22.

[Relation between certain diseases and frequency of depression in geriatric patients].

Zietemann V, Zietemann P, Weitkunat R, Kwetkat A.

Nervenarzt. 2007 Jun;78(6):657-64. German.

PMID:
16821065
23.

Sex-specific usage patterns of sleeping sites in grey mouse lemurs (Microcebus murinus) in northwestern Madagascar.

Radespiel U, Cepok S, Zietemann V, Zimmermann E.

Am J Primatol. 1998;46(1):77-84.

PMID:
9730214
24.

Sympatric mouse lemurs in north-west Madagascar: a new rufous mouse lemur species (Microcebus ravelobensis).

Zimmermann E, Cepok S, Rakotoarison N, Zietemann V, Radespiel U.

Folia Primatol (Basel). 1998;69(2):106-14. No abstract available.

PMID:
9583951

Supplemental Content

Loading ...
Support Center